Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ABL1 inhibitors(ABL proto-oncogene 1 inhibitors), LRRK2 inhibitors(Leucine-rich repeat serine/threonine-protein kinase 2 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization 1st Biotherapeutics, Inc.Startup |
Active Organization 1st Biotherapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Phase 1 | - | 1st Biotherapeutics, Inc.Startup | 01 Dec 2023 |
Parkinson Disease | Phase 1 | - | 1st Biotherapeutics, Inc.Startup | 01 Dec 2023 |